Millennium Management’s Annovis Bio ANVS Stock Holding History

Millennium Management’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.6K	Buy	+23,463	New	+$45.6K	﹤0.01%	5632
2022 Q2	–	Sell	-62,676	Closed	-$837K	–	6932
2022 Q1	$837K	Sell	62,676 -4,468	-7%	-$64.6K	﹤0.01%	4702
2021 Q4	$1.18M	Buy	67,144 +1,525	+2%	+$39.3K	﹤0.01%	4259
2021 Q3	$2.08M	Buy	65,619 +62,032	+1,729%	+$3.57M	﹤0.01%	3855
2021 Q2	$307K	Buy	+3,587	New	+$166K	﹤0.01%	5702
2020 Q3	–	Sell	-38,179	Closed	-$166K	–	4405
2020 Q2	$166K	Buy	+38,179	New	+$158K	﹤0.01%	3889

Other funds holding ANVS

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Millennium Management's ANVS Position: Q2 2026 in Review

Millennium Management opened a new position in Annovis Bio (ANVS) in Q2 2026: 23,463 shares worth $43.6K. The stake represents ﹤0.01% of the portfolio and ranks #5632 among its holdings. This is a return to the name: Millennium Management previously reported a position in ANVS as recently as Q1 2022.

Millennium Management first reported a position in ANVS in Q2 2020 and has held it in 6 quarters since. The position peaked at $2.08M in Q3 2021. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Millennium Management held 23,463 shares of Annovis Bio worth $43.6K as of Q2 2026.
Annovis Bio was a new Millennium Management position in Q2 2026.
Annovis Bio made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #5632 holding.
Millennium Management first reported a position in Annovis Bio in Q2 2020 and has held it in 6 quarters since.
Millennium Management's Annovis Bio position peaked at $2.08M in Q3 2021.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.